David A. Socks, SVP at CADENCE PHARMACEUTICALS INC (CADX), sold 12,500 shares at $10.72 ($134K) on 2009-09-14, disclosed to the SEC on 2009-09-15.
Scheduled sale ($134k) by SVP under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.57 | 2,500 | $26K | 19.8% |
| 2 | $10.72 | 10,000 | $107K | 80.2% |
| Total | $10.69 avg | 12,500 | $134K | 100% |
| Filing → |
| PHAT | SELL | 2021-08-18 | $1.1M | — | Filing → |
| PHAT | SELL | 2021-06-29 | $2.2M | — | Filing → |
| PHAT | SELL | 2021-05-21 | $2.6M | — | Filing → |